Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1986-04-29
1987-09-01
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
046909494
ABSTRACT:
A therapeutic drug for dementia is provided which comprises, as an active ingredient, DL- or L-threo-3,4-dihydroxyphenylserine of the formula ##STR1## or its salt.
REFERENCES:
patent: 3920728 (1975-11-01), Hegedus
patent: 4330558 (1982-05-01), Suzuki
patent: 4499726 (1985-02-01), Narabayashi
patent: 4529603 (1985-07-01), Mori
Chem. Abst. 101-73099c (1984).
The Lancet "Selective Loss of Neurones of Origin . . . " Bondareff, Mountjoy, Roth Apr. 14, 1981, pp. 783-784.
Journal of Neurology, Neurosugery and Psychiatry, pp. 113-119, 1982, "The Noradrenergic System . . . " Mamann, et al.
British Medical Journal, vol. 282, pp. 93-94, "Reduced Dopamine-Beta-Hydroxylase . . . " Cross et al.
Dobutsu Masakatsu
Furukawa Yuusuke
Joshita Yutaka
Mizuno Yoshikuni
Otsuka Mieko
Friedman Stanley J.
Sumitomo Pharmaceuticals Company Limited
LandOfFree
Therapeutic drug for dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic drug for dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic drug for dementia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265213